首页 > 最新文献

International Journal of Tuberculosis and Lung Disease最新文献

英文 中文
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB. 用 LAMP 检测面罩过滤器样本的评估显示,肺结核的检出率很高。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0190
T Kodama, K Chikamatsu, K Kamada, K Mizuno, Y Morishige, Y Igarashi, A Osugi, A Aono, Y Murase, M Okumura, T Yoshiyama, A Takaki, S Mitarai

BACKGROUNDDetection of Mycobacterium tuberculosis (MTB) in bioaerosols derived from patients with active pulmonary TB is a potential alternative diagnostic method for patients with presumed TB who cannot expectorate sputum.OBJECTIVETo assess the efficacy of a bioaerosol particle collection method to capture MTB and diagnose TB.METHODSA mask-like filter holder (3D mask) with a water-soluble gelatine filter (GF) and one containing a water-insoluble polypropylene filter (PPF) were prepared. Eligible patients wore the 3D mask with GF or PPF within 3 days of starting anti-TB drugs. The GF and PPF filters were collected after 2 and 8 h. DNA was extracted from the filter samples and tested using loop-mediated isothermal amplification (LAMP).RESULTSFilter samples were collected from 57 and 20 patients with and without active pulmonary TB, respectively. The GF and PPF sensitivity was 76.2% and 83.3%, respectively. The specificity of both methods was 100%. Of the 57 patients diagnosed with non-expectorated sputum samples, including suction phlegm, gastric lavage, and bronchial lavage fluid, 55.6% and 50.0% were positive by GF and PPF, respectively.CONCLUSIONWe present a 3D mask filter sampling method for exhaled bioaerosol particles that can be used in clinical practice to diagnose patients with presumed TB..

背景从活动性肺结核患者产生的生物气溶胶中检测结核分枝杆菌(MTB)是一种潜在的替代诊断方法,适用于无法排痰的推测肺结核患者。符合条件的患者在开始服用抗结核药物后 3 天内佩戴装有 GF 或 PPF 的三维口罩。结果分别从 57 名和 20 名活动性肺结核患者和非活动性肺结核患者身上采集了过滤器样本。GF 和 PPF 的灵敏度分别为 76.2% 和 83.3%。两种方法的特异性均为 100%。在 57 名诊断为非排痰(包括吸痰、洗胃和支气管灌洗液)的患者中,GF 和 PPF 的阳性率分别为 55.6% 和 50.0%。
{"title":"Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB.","authors":"T Kodama, K Chikamatsu, K Kamada, K Mizuno, Y Morishige, Y Igarashi, A Osugi, A Aono, Y Murase, M Okumura, T Yoshiyama, A Takaki, S Mitarai","doi":"10.5588/ijtld.24.0190","DOIUrl":"https://doi.org/10.5588/ijtld.24.0190","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Detection of <i>Mycobacterium tuberculosis</i> (MTB) in bioaerosols derived from patients with active pulmonary TB is a potential alternative diagnostic method for patients with presumed TB who cannot expectorate sputum.</sec><sec><title>OBJECTIVE</title>To assess the efficacy of a bioaerosol particle collection method to capture MTB and diagnose TB.</sec><sec><title>METHODS</title>A mask-like filter holder (3D mask) with a water-soluble gelatine filter (GF) and one containing a water-insoluble polypropylene filter (PPF) were prepared. Eligible patients wore the 3D mask with GF or PPF within 3 days of starting anti-TB drugs. The GF and PPF filters were collected after 2 and 8 h. DNA was extracted from the filter samples and tested using loop-mediated isothermal amplification (LAMP).</sec><sec><title>RESULTS</title>Filter samples were collected from 57 and 20 patients with and without active pulmonary TB, respectively. The GF and PPF sensitivity was 76.2% and 83.3%, respectively. The specificity of both methods was 100%. Of the 57 patients diagnosed with non-expectorated sputum samples, including suction phlegm, gastric lavage, and bronchial lavage fluid, 55.6% and 50.0% were positive by GF and PPF, respectively.</sec><sec><title>CONCLUSION</title>We present a 3D mask filter sampling method for exhaled bioaerosol particles that can be used in clinical practice to diagnose patients with presumed TB.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"476-481"},"PeriodicalIF":3.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health status of Italian children living close to cultivations sprayed with pesticides. 生活在喷洒过杀虫剂的农田附近的意大利儿童的健康状况。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0104
G Sarno, S Maio, S Baldacci, I Stanisci, A Angino, S Tagliaferro, P Silvi, G Viegi

BACKGROUNDPesticides are used to control pests, but they are toxic and may severely harm children's health. We assessed health outcomes in Italian children living close to cultivations sprayed with pesticides.METHODSIn 2011-2012, 2,367 schoolchildren (6-14 years) living in eight Italian cities participated in the Indoor-School observational study. Parents filled in a standardised questionnaire on children's health and related risk factors. Children were classified as exposed to pesticides if living close to cultivations sprayed with pesticides. The association between the last three months of respiratory, allergic or systemic symptoms and pesticide exposure was assessed by multinomial logistic regression models, accounting for host/environmental risk factors.RESULTSOverall, 14% of children were exposed to pesticides, with significant differences among geographical areas: 21.2% in Northern Italy, 11.6% in Central Italy, and 9.7% in Southern Italy. Pesticide exposure was significantly associated with having: 1) 'often': eye symptoms (OR 3.81, 95% CI 2.06-7.05), skin symptoms (OR 2.60, 95% CI 1.34-5.03), lower airway symptoms (OR 2.38, 95% CI 1.41-4.01), systemic symptoms (OR 1.56, 95% CI 0.96-2.53, borderline); 2) 'daily': upper airways symptoms (OR 2.25, 95% CI 1.25-4.07) and systemic symptoms (OR 2.76, 95% CI 1.43-5.34).CONCLUSIONSSelf-reported pesticide exposure was associated with respiratory, allergic or systemic symptoms in children. Public authorities should be aware of and intervene to mitigate this health risk..

背景杀虫剂用于控制害虫,但它们具有毒性,可能会严重危害儿童健康。我们对居住在喷洒过杀虫剂的农田附近的意大利儿童的健康状况进行了评估。方法 2011-2012年,居住在意大利八个城市的2367名学龄儿童(6-14岁)参加了室内-学校观察研究。家长填写了一份关于儿童健康和相关风险因素的标准化问卷。如果儿童居住的地方靠近喷洒过杀虫剂的农田,则被归类为接触过杀虫剂的儿童。通过多项式逻辑回归模型评估了最近三个月出现的呼吸道、过敏或全身症状与接触杀虫剂之间的关系,并考虑了宿主/环境风险因素:意大利北部为 21.2%,意大利中部为 11.6%,意大利南部为 9.7%。接触杀虫剂与以下情况有明显关系2)"每日":上呼吸道症状(OR 2.25,95% CI 1.25-4.07)和全身症状(OR 2.76,95% CI 1.43-5.34)。公共当局应该意识到并采取干预措施来降低这种健康风险。
{"title":"Health status of Italian children living close to cultivations sprayed with pesticides.","authors":"G Sarno, S Maio, S Baldacci, I Stanisci, A Angino, S Tagliaferro, P Silvi, G Viegi","doi":"10.5588/ijtld.24.0104","DOIUrl":"https://doi.org/10.5588/ijtld.24.0104","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Pesticides are used to control pests, but they are toxic and may severely harm children's health. We assessed health outcomes in Italian children living close to cultivations sprayed with pesticides.</sec><sec><title>METHODS</title>In 2011-2012, 2,367 schoolchildren (6-14 years) living in eight Italian cities participated in the Indoor-School observational study. Parents filled in a standardised questionnaire on children's health and related risk factors. Children were classified as exposed to pesticides if living close to cultivations sprayed with pesticides. The association between the last three months of respiratory, allergic or systemic symptoms and pesticide exposure was assessed by multinomial logistic regression models, accounting for host/environmental risk factors.</sec><sec><title>RESULTS</title>Overall, 14% of children were exposed to pesticides, with significant differences among geographical areas: 21.2% in Northern Italy, 11.6% in Central Italy, and 9.7% in Southern Italy. Pesticide exposure was significantly associated with having: 1) 'often': eye symptoms (OR 3.81, 95% CI 2.06-7.05), skin symptoms (OR 2.60, 95% CI 1.34-5.03), lower airway symptoms (OR 2.38, 95% CI 1.41-4.01), systemic symptoms (OR 1.56, 95% CI 0.96-2.53, borderline); 2) 'daily': upper airways symptoms (OR 2.25, 95% CI 1.25-4.07) and systemic symptoms (OR 2.76, 95% CI 1.43-5.34).</sec><sec><title>CONCLUSIONS</title>Self-reported pesticide exposure was associated with respiratory, allergic or systemic symptoms in children. Public authorities should be aware of and intervene to mitigate this health risk.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"500-504"},"PeriodicalIF":3.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TB outpatient care in a high-income, low-incidence country. 一个高收入、低发病率国家的结核病门诊护理。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.5588/ijtld.24.0059
N Riccardi, C Monari, R M Antonello, L Saderi, S Occhineri, A Pontarelli, P Zucchi, D Buonsenso, E Falbo, P Faverio, S Aliberti, R Parrella, M Falcone, G Besozzi, A Calcagno, D Goletti, G Gualano, G Sotgiu, M Tadolini, L Codecasa
{"title":"TB outpatient care in a high-income, low-incidence country.","authors":"N Riccardi, C Monari, R M Antonello, L Saderi, S Occhineri, A Pontarelli, P Zucchi, D Buonsenso, E Falbo, P Faverio, S Aliberti, R Parrella, M Falcone, G Besozzi, A Calcagno, D Goletti, G Gualano, G Sotgiu, M Tadolini, L Codecasa","doi":"10.5588/ijtld.24.0059","DOIUrl":"https://doi.org/10.5588/ijtld.24.0059","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 10","pages":"513-515"},"PeriodicalIF":3.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory impairment after completion of TB treatment: a neglected but vitally important issue. 肺结核治疗结束后的呼吸系统损伤:一个被忽视但极其重要的问题。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0341
L N Nguyen, P T Phan, E Jaramillo, A Dinh, A T Dinh-Xuan
{"title":"Respiratory impairment after completion of TB treatment: a neglected but vitally important issue.","authors":"L N Nguyen, P T Phan, E Jaramillo, A Dinh, A T Dinh-Xuan","doi":"10.5588/ijtld.24.0341","DOIUrl":"10.5588/ijtld.24.0341","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"410-411"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cold temperatures during sample transportation may cause false-negative interferon-γ release assays used to diagnose TB infection. 样本运输过程中的低温可能会导致用于诊断肺结核感染的干扰素-γ 释放检测出现假阴性。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0020
K Takeda, H Nagai, M Kawashima, I Kosai, M Shimozono, K Sato, H Motomura, E Nakano, M Watanabe, T Kato, M Shimada, O Narumoto, M Suzukawa, J Suzuki, K Yamane, Y Sasaki, Y Morio, A Tamura, H Matsui
{"title":"Cold temperatures during sample transportation may cause false-negative interferon-γ release assays used to diagnose TB infection.","authors":"K Takeda, H Nagai, M Kawashima, I Kosai, M Shimozono, K Sato, H Motomura, E Nakano, M Watanabe, T Kato, M Shimada, O Narumoto, M Suzukawa, J Suzuki, K Yamane, Y Sasaki, Y Morio, A Tamura, H Matsui","doi":"10.5588/ijtld.24.0020","DOIUrl":"10.5588/ijtld.24.0020","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"467-469"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Miliary TB in children and adolescents: a scoping review. 儿童和青少年的传染性结核病:范围界定综述。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.24.0106
D Buonsenso, F Mariani, R Morello, R Song

OBJECTIVETo summarise the available literature regarding clinical presentation, immunological and microbiological diagnosis, treatment, and outcomes of miliary TB in children and adolescents.METHODSFour databases were searched from 1 January 1950 to 31 January 2023. "Miliary" and "disseminated" TB were the main search concepts.FINDINGSOf 257 studies, 1,883 patients with miliary TB were included. Bacille Calmette-Guérin (BCG) vaccination was confirmed in 223/549 (40.6%) children. Central nervous system (CNS) involvement was reported in 367/924 (39.7%) cases; many of them had no neurological symptoms despite also having abnormal brain imaging. Of 1,112 children with known outcomes, 341 (30.6%) died; mortality was higher in publications before 1995 (41.5%) and in children with CNS involvement (31.9%). TB microbiological confirmation (55.8%) and sensitivity of tuberculin skin test (46.9%) and QuantiFERON Gold (72.4%) were overall low.CONCLUSIONSEvidence is lacking to support best practices for paediatric miliary TB. Whether lumbar puncture (LP) and brain imaging should both be routinely done in miliary TB children, or a step-by-step approach based on initial LP findings, remains unclear. This study should inform policymakers and funding agencies about current significant gaps that need to be addressed by future high-quality studies..

目的总结有关儿童和青少年粟粒性肺结核的临床表现、免疫学和微生物学诊断、治疗和结果的现有文献。方法检索 1950 年 1 月 1 日至 2023 年 1 月 31 日的四个数据库。"结果在 257 项研究中,共纳入了 1,883 名粟粒性肺结核患者。223/549(40.6%)名儿童证实接种过卡介苗(BCG)。据报告,367/924(39.7%)例患者的中枢神经系统(CNS)受累;其中许多人没有神经系统症状,尽管脑成像也异常。在已知结果的 1112 名儿童中,有 341 人(30.6%)死亡;1995 年以前发表的病例死亡率较高(41.5%),中枢神经系统受累的儿童死亡率也较高(31.9%)。结核病微生物学确诊率(55.8%)、结核菌素皮试灵敏度(46.9%)和定量FERON Gold(72.4%)总体较低。腰椎穿刺(LP)和脑成像是否都应作为治疗儿童淤胆型肺结核的常规方法,还是应根据最初的腰椎穿刺结果采取循序渐进的方法,目前仍不清楚。这项研究应让政策制定者和资助机构了解目前存在的重大差距,这些差距需要通过未来的高质量研究来弥补。
{"title":"Miliary TB in children and adolescents: a scoping review.","authors":"D Buonsenso, F Mariani, R Morello, R Song","doi":"10.5588/ijtld.24.0106","DOIUrl":"10.5588/ijtld.24.0106","url":null,"abstract":"<p><p><sec><title>OBJECTIVE</title>To summarise the available literature regarding clinical presentation, immunological and microbiological diagnosis, treatment, and outcomes of miliary TB in children and adolescents.</sec><sec><title>METHODS</title>Four databases were searched from 1 January 1950 to 31 January 2023. \"Miliary\" and \"disseminated\" TB were the main search concepts.</sec><sec><title>FINDINGS</title>Of 257 studies, 1,883 patients with miliary TB were included. Bacille Calmette-Guérin (BCG) vaccination was confirmed in 223/549 (40.6%) children. Central nervous system (CNS) involvement was reported in 367/924 (39.7%) cases; many of them had no neurological symptoms despite also having abnormal brain imaging. Of 1,112 children with known outcomes, 341 (30.6%) died; mortality was higher in publications before 1995 (41.5%) and in children with CNS involvement (31.9%). TB microbiological confirmation (55.8%) and sensitivity of tuberculin skin test (46.9%) and QuantiFERON Gold (72.4%) were overall low.</sec><sec><title>CONCLUSIONS</title>Evidence is lacking to support best practices for paediatric miliary TB. Whether lumbar puncture (LP) and brain imaging should both be routinely done in miliary TB children, or a step-by-step approach based on initial LP findings, remains unclear. This study should inform policymakers and funding agencies about current significant gaps that need to be addressed by future high-quality studies.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"412-418"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs. 糖尿病对结核病药物代谢动力学影响的系统回顾。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.5588/ijtld.23.0507
M Cevik, A Sturdy, A E Maraolo, B G J Dekkers, O W Akkerman, S H Gillespie, J W C Alffenaar

OBJECTIVESThe coexistence of TB and diabetes mellitus (DM) (TB-DM) is associated with an increased risk of treatment failure, death, delayed culture conversion, and drug resistance. Because plasma concentrations may influence clinical outcomes, we evaluated the evidence on the pharmacokinetic (PK) of TB drugs in individuals with DM to guide management.METHODSWe performed a systematic review and meta-analysis through searches of major databases from 1946 to 6 July 2023. PROSPERO (CRD42022323566).RESULTSOf 4,173 potentially relevant articles, we identified 16 studies assessing rifampicin (RIF) PK, 9 on isoniazid (INH), 8 on pyrazinamide (PZA), and 3 on ethambutol (EMB). Two studies reported on second-line anti-TB drugs. According to our meta-analysis, RIF time to maximum concentration (Tmax) was significantly prolonged in patients with DM compared with non-DM patients. We found no significant differences for RIF Cmax, area under the curve (AUC) 0-24 or drug concentration at 2 h (C2h), INH C2h, PZA C2h, PZA Tmax, and EMB Tmax. Although RIF C2h was slightly reduced in patients with TB-DM, this finding was not statistically significant.CONCLUSIONSThis review comprehensively examines the impact of DM on the PK of TB drugs. We observed significant heterogeneity among the studies. Given the association between lower plasma concentrations and poor clinical outcomes among patients with DM, we recommend a higher dose limit to compensate for the larger body weight of patients with DM..

目的结核病和糖尿病(DM)并存(TB-DM)与治疗失败、死亡、培养转换延迟和耐药性风险增加有关。由于血浆浓度可能会影响临床结果,因此我们评估了结核病药物在糖尿病患者体内的药代动力学(PK)证据,以指导治疗。方法我们通过检索 1946 年至 2023 年 7 月 6 日期间的主要数据库,进行了系统综述和荟萃分析。结果在 4,173 篇可能相关的文章中,我们发现了 16 篇评估利福平 (RIF) PK 的研究、9 篇评估异烟肼 (INH) PK 的研究、8 篇评估吡嗪酰胺 (PZA) PK 的研究和 3 篇评估乙胺丁醇 (EMB) PK 的研究。两项研究报告了二线抗结核药物。根据我们的荟萃分析,与非 DM 患者相比,DM 患者 RIF 达到最大浓度(Tmax)的时间明显延长。我们发现 RIF Cmax、0-24 小时曲线下面积(AUC)或 2 小时药物浓度(C2h)、INH C2h、PZA C2h、PZA Tmax 和 EMB Tmax 均无明显差异。虽然 RIF C2h 在 TB-DM 患者中略有降低,但这一结果并无统计学意义。我们观察到研究之间存在明显的异质性。鉴于 DM 患者较低的血浆浓度与较差的临床结果之间存在关联,我们建议采用较高的剂量限制,以补偿 DM 患者较大的体重。
{"title":"A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs.","authors":"M Cevik, A Sturdy, A E Maraolo, B G J Dekkers, O W Akkerman, S H Gillespie, J W C Alffenaar","doi":"10.5588/ijtld.23.0507","DOIUrl":"10.5588/ijtld.23.0507","url":null,"abstract":"<p><p><sec><title>OBJECTIVES</title>The coexistence of TB and diabetes mellitus (DM) (TB-DM) is associated with an increased risk of treatment failure, death, delayed culture conversion, and drug resistance. Because plasma concentrations may influence clinical outcomes, we evaluated the evidence on the pharmacokinetic (PK) of TB drugs in individuals with DM to guide management.</sec><sec><title>METHODS</title>We performed a systematic review and meta-analysis through searches of major databases from 1946 to 6 July 2023. PROSPERO (CRD42022323566).</sec><sec><title>RESULTS</title>Of 4,173 potentially relevant articles, we identified 16 studies assessing rifampicin (RIF) PK, 9 on isoniazid (INH), 8 on pyrazinamide (PZA), and 3 on ethambutol (EMB). Two studies reported on second-line anti-TB drugs. According to our meta-analysis, RIF time to maximum concentration (T<sub>max</sub>) was significantly prolonged in patients with DM compared with non-DM patients. We found no significant differences for RIF C<sub>max</sub>, area under the curve (AUC) 0-24 or drug concentration at 2 h (C2h), INH C2h, PZA C2h, PZA T<sub>max</sub>, and EMB T<sub>max</sub>. Although RIF C2h was slightly reduced in patients with TB-DM, this finding was not statistically significant.</sec><sec><title>CONCLUSIONS</title>This review comprehensively examines the impact of DM on the PK of TB drugs. We observed significant heterogeneity among the studies. Given the association between lower plasma concentrations and poor clinical outcomes among patients with DM, we recommend a higher dose limit to compensate for the larger body weight of patients with DM.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 9","pages":"454-460"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Programmatic implications of a sub-national TB prevalence survey in India. 印度次国家级结核病流行率调查对计划的影响。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-01 DOI: 10.5588/ijtld.23.0456
G Prathiksha, S Selvaraju, K Thiruvengadam, A Frederick, H Murugesan, P Rajendran, K Nagarajan, M Kumar, R Krishnan, P Kumaran, T S Selvavinayagam, C Padmapriyadarsini

BACKGROUNDSubnational TB estimates are crucial for making informed decisions to tailor TB control activities to local TB epidemiology.METHODSA cross-sectional survey was conducted among 143,005 individuals in Tamil Nadu, India. Participants were screened for symptoms and underwent chest X-ray (CXR). Participants with symptoms of TB and/or abnormal CXR were tested for TB using Xpert, smear, and liquid culture.RESULTSThe prevalence of microbiologically confirmed pulmonary TB (MCPTB) was 212 (95% CI 184-239) per 100,000 population. The prevalence-to-notification ratio (P:N) in the state was 2.05 (95% CI 1.8-2.29). Low body mass index and diabetes together had a population attributable fraction of 54.15 (95% CI 45.68-61.97). Approximately 39% of the TB cases were asymptomatic and were identified only by CXR screening. In the general population, only 26.9% sought care at a health facility among those with symptoms suggestive of TB.CONCLUSIONThe programme needs to prioritise screening with CXR to potentially detect cases earlier and curtail the transmission and upscale molecular tests in the selected population to increase the yield of case finding. Innovative health education strategies must be devised to address health-seeking behaviour..

背景国家以下各级的结核病估计数对于根据当地结核病流行情况制定明智的结核病控制活动至关重要。参与者接受了症状筛查和胸部 X 光检查(CXR)。结果经微生物确诊的肺结核(MCPTB)发病率为每 10 万人 212 例(95% CI 184-239)。该州的发病率与通知率(P:N)为 2.05(95% CI 1.8-2.29)。低体重指数和糖尿病的人口可归因比例为 54.15(95% CI 45.68-61.97)。约 39% 的肺结核病例无症状,仅通过 CXR 筛查发现。在普通人群中,只有 26.9% 的人在出现肺结核症状时到医疗机构就诊。必须制定创新的健康教育战略,以解决寻求健康的行为问题。
{"title":"Programmatic implications of a sub-national TB prevalence survey in India.","authors":"G Prathiksha, S Selvaraju, K Thiruvengadam, A Frederick, H Murugesan, P Rajendran, K Nagarajan, M Kumar, R Krishnan, P Kumaran, T S Selvavinayagam, C Padmapriyadarsini","doi":"10.5588/ijtld.23.0456","DOIUrl":"https://doi.org/10.5588/ijtld.23.0456","url":null,"abstract":"<p><p><sec><title>BACKGROUND</title>Subnational TB estimates are crucial for making informed decisions to tailor TB control activities to local TB epidemiology.</sec><sec><title>METHODS</title>A cross-sectional survey was conducted among 143,005 individuals in Tamil Nadu, India. Participants were screened for symptoms and underwent chest X-ray (CXR). Participants with symptoms of TB and/or abnormal CXR were tested for TB using Xpert, smear, and liquid culture.</sec><sec><title>RESULTS</title>The prevalence of microbiologically confirmed pulmonary TB (MCPTB) was 212 (95% CI 184-239) per 100,000 population. The prevalence-to-notification ratio (P:N) in the state was 2.05 (95% CI 1.8-2.29). Low body mass index and diabetes together had a population attributable fraction of 54.15 (95% CI 45.68-61.97). Approximately 39% of the TB cases were asymptomatic and were identified only by CXR screening. In the general population, only 26.9% sought care at a health facility among those with symptoms suggestive of TB.</sec><sec><title>CONCLUSION</title>The programme needs to prioritise screening with CXR to potentially detect cases earlier and curtail the transmission and upscale molecular tests in the selected population to increase the yield of case finding. Innovative health education strategies must be devised to address health-seeking behaviour.</sec>.</p>","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 7","pages":"348-353"},"PeriodicalIF":3.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose. 与意外服用利福喷丁过量有关的结合型高胆红素血症。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-01 DOI: 10.5588/ijtld.23.0494
M Yohane, F Naufal, A Mendoza-Ticona, E M Svensson, I R Weir, K K Scarsi, D W Haas, G Maartens, J Metcalfe
{"title":"Conjugated hyperbilirubinemia associated with accidental rifapentine overdose.","authors":"M Yohane, F Naufal, A Mendoza-Ticona, E M Svensson, I R Weir, K K Scarsi, D W Haas, G Maartens, J Metcalfe","doi":"10.5588/ijtld.23.0494","DOIUrl":"10.5588/ijtld.23.0494","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 7","pages":"354-356"},"PeriodicalIF":3.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11392536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB. 从治疗耐药性结核病中汲取的经验教训,以及如何将这些经验教训应用于耐药性结核病。
IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-01 DOI: 10.5588/ijtld.23.0548
N Godefroy, G Monsel, S Jauréguiberry, B Henry, N Véziris, A Aubry, J Robert, M Jachym, E Caumes, V Pourcher
{"title":"Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB.","authors":"N Godefroy, G Monsel, S Jauréguiberry, B Henry, N Véziris, A Aubry, J Robert, M Jachym, E Caumes, V Pourcher","doi":"10.5588/ijtld.23.0548","DOIUrl":"https://doi.org/10.5588/ijtld.23.0548","url":null,"abstract":"","PeriodicalId":14411,"journal":{"name":"International Journal of Tuberculosis and Lung Disease","volume":"28 7","pages":"357-359"},"PeriodicalIF":3.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Tuberculosis and Lung Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1